Company Overview - Generation Bio is a biotechnology company focused on developing therapeutics for T cell-driven autoimmune diseases [3] - The company utilizes a novel approach with T cell-selective cell-targeted lipid nanoparticles (ctLNP) to deliver siRNA in vivo, aiming to modulate T cell activity responsible for inflammation and tissue destruction [3] - This new modality is designed to effectively target areas that are challenging to address with existing therapies, potentially expanding treatment options for various autoimmune diseases [3] Upcoming Event - Geoff McDonough, M.D., the president and CEO of Generation Bio, will present at the TD Cowen 45th Annual Health Care Conference on March 3, 2025, at 9:10 a.m. ET in Boston [1] - A live webcast of the presentation will be accessible on the investor section of the company's website, with a replay available for 30 days post-event [2]
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference